Mukka Proteins (NSE:MUKKA) Current Deferred Revenue: ₹0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:MUKKA Mukka Proteins Ltd NSE:MUKKA
40 GF Score
Price ₹29.86
! 7 Warning Signs
View Full Analysis

What is Mukka Proteins Current Deferred Revenue?

Mukka Proteins NSE:MUKKA -2.80% 40 Current Deferred Revenue is ₹0 Mil as of Jun. 2026. GuruFocus rates NSE:MUKKA with a GF Score™ of 40/100. The stock has 7 warning signs investors should review.

Current Deferred Revenue represents collections of cash or other assets related to revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP. It can be either current or non-current item. Also called unearned revenue.

Mukka Proteins's current deferred revenue for the quarter that ended in Jun. 2026 was ₹0 Mil.

Mukka Proteins Current Deferred Revenue Related Terms

Mukka Proteins Current Deferred Revenue Historical Data

* Premium members only.

The historical data trend for Mukka Proteins's Current Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Mukka Proteins Current Deferred Revenue Chart

Mukka Proteins Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Current Deferred Revenue
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Mukka Proteins Quarterly Data
Mar19 Mar20 Mar21 Sep21 Mar22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Current Deferred Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
NSE:MUKKA
40GF Score
Mukka Proteins Ltd NSE:MUKKA
Current Deferred Revenue is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Current Deferred Revenue of ₹0 Mil mean?
Mukka Proteins (NSE:MUKKA) has a Current Deferred Revenue of ₹0 Mil as of Jun. 2026. Current Deferred Revenue records the total amount of cash received for unfinished services. View historical data on Mukka Proteins and its competitors.
Is Mukka Proteins' Current Deferred Revenue too high?
Mukka Proteins' current Current Deferred Revenue is ₹0 Mil. Overall, Mukka Proteins has a GF Score™ of 40/100, reflecting its overall financial health beyond just this single metric.
How does Mukka Proteins' Current Deferred Revenue compare to KHC and GIS?
Mukka Proteins' Current Deferred Revenue of ₹0 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Deferred Revenue for a Consumer Packaged Goods company?
A good Current Deferred Revenue depends on the Consumer Packaged Goods industry context. However, Current Deferred Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Deferred Revenue mean?
A high Current Deferred Revenue can signal that a stock is expensive relative to its fundamentals. Current Deferred Revenue records the total amount of cash received for unfinished services. View historical data on Mukka Proteins and its competitors. Mukka Proteins's current Current Deferred Revenue is ₹0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mukka Proteins stock overvalued right now?
Mukka Proteins (NSE:MUKKA) has a current Current Deferred Revenue of ₹0 Mil. The current Current Deferred Revenue is ₹0 Mil. Mukka Proteins' overall GF Score™ is 40/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Deferred Revenue calculated?
Current Deferred Revenue is calculated from a company's financial statements. For Mukka Proteins (NSE:MUKKA), the current Current Deferred Revenue is ₹0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Mukka Proteins Business Description

Other Exchanges 544135:India
Address NG Road, Mukka Corporate House, Door No. 18-2-16/4, First Cross, Attavara, Dakshina Kannada, Mangaluru, KA, IND, 575001
Mukka Proteins Ltd is an animal protein company. The company manufactures and supplies fish meal, fish oil, and fish soluble paste, which is an essential ingredient in the manufacturing of aqua feed (for fish and shrimp), poultry feed (for broilers and layers), and pet food. Fish oil of the company also finds its application in pharmaceutical products (additionally, Omega-3 pills and related products derived from fish oil are gaining importance as high-nutrient and healthy dietary supplements), soap manufacturing, leather tanneries & paint industries. The company sells its products domestically and also exports them to over 10 countries, including Bahrain, Bangladesh, Chile, Indonesia, Malaysia, Myanmar, Philippines, China, Saudi Arabia, South Korea, Oman, Taiwan, and Vietnam.
40GF Score

Get the complete analysis for NSE:MUKKA

Current Deferred Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹29.86
Price